Yoshioka, Kenji
Maeda, Daichi
Okumura, Takahiro
Kida, Keisuke
Oishi, Shogo
Akiyama, Eiichi
Suzuki, Satoshi
Yamamoto, Masayoshi
Mizukami, Akira
Kuroda, Shunsuke
Kagiyama, Nobuyuki
Yamaguchi, Tetsuo
Sasano, Tetsuo
Matsumura, Akihiko
Kitai, Takeshi
Matsue, Yuya
Funding for this research was provided by:
The Cardiovascular Research Fund
Japan Society for the Promotion of Science (21H03309)
Article History
Received: 26 August 2021
Accepted: 24 January 2022
First Online: 8 February 2022
Competing interests
: Dr Takahoro Okumura received honoraria from Ono Yakuhin, Novartis, AstraZeneca, and Otsuka, and research grants from Ono Yakuhin, Amgen Astellas, Pfizer, Alexion, and Alnylam (not in connection with the submitted work). Dr Keisuke Kida received honoraria from Daichi Sankyo Co., Ono Yakuhin, AstraZeneca, Otsukaand Novartis. Dr. Nobuyuki Kagiyama is affiliated with a department funded by Philips Healthcare, Asahi KASEI Corporation, Inter Reha Co., Ltd, and Toho Holdings Co., Ltd based on collaborative research agreement. Dr. Yuya Matsue is affiliated with a department endowed by Philips Respironics, ResMed, Teijin Home Healthcare, and Fukuda Denshi. Dr. Yuya Matsue received honorariums from Otsuka Pharmaceutical Co. and Novartis Japan. The remaining authors have no conflicts of interest to declare.